STENTYS (FR0010949404 – STNT), a medical technology company commercializing the world’s first and only Self-Apposing® stent to treat acute myocardial infarction (AMI), today announced its consolidated, audited revenues for the fourth quarter and full year 2013.
Help employers find you! Check out all the jobs and post your resume.
